https://www.selleckchem.com/pr....oducts/conteltinib-c
y provide strong evidence for the clinical use of JTTF in the treatment of T2DM and NAFLD, leading to the possibility of further mechanistic exploration. Clinical Trial Registration This clinical trial has been registered in China Clinical Trial Registry (ChiCTR 2100051174).Background Ectopic activation of renin-angiotensin-system contributes to cardiovascular and renal diseases. (Pro)renin receptor (PRR) binds to renin and prorenin, participating in the progression of nephrology. However, whether PRR could be considered as a
Mi piace
Commento
Condividi
